Información del producto
- N-Acetyl-N-methyl-L-alanine [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8 ,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl esterMaytansine
- (2'R,3beta,4beta,6beta,7beta,9beta)-maytansine
- (3Beta,4Beta,6Beta,7Beta,9Beta)-Maytansine
- (4beta,11E,13E)-maytansine
- 4,24-Dioxa-9,22-diazatetracyclo[19.3.1.1<sup>10,14</sup>.0<sup>3,5</sup>]hexacosane, maytansine deriv.
- <span class="text-smallcaps">L</span>-Alanine, N-acetyl-N-methyl-, 11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1<sup>10,14</sup>.0<sup>3,5</sup>]hexacosa-10,12,14(26),16,18-pentaen-6-yl ester, [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-
- Brn 5417399
- L-Alanine, N-acetyl-N-methyl-, 11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo(19.3.1.110,14.03,5)hexacosa-10,12,14(26),16,18-pentaen-6-yl ester, (1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*))-
- Maitansina
- Maitansina [INN-Spanish]
- Ver más sinónimos
- Maitansinum
- Maitansinum [INN-Latin]
- Maysanine
- Maytansin
- Maytansine
- Maytansine [USAN]
- N-Acetyl-N-methyl-<span class="text-smallcaps">L</span>-alanine [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1<sup>10,14</sup>.0<sup>3,5</sup>]hexacosa-10,12,14(26),16,18-pentaen-6-yl ester
- N-Acetyl-N-methyl-L-alanine(1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*))-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethy-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo(19.3.1.1(sup 10,14).0(sup 3,5))hexacosa-10,12,14(26),16,18-pentaen-6-yl ester
- Nsc 153858
- Unii-14083Fr882
NSC 153858 is a conjugate of the antibody murine sarcoma virus (MSV) with maytansine. It has been shown to be effective against breast cancer and other cancers. The MSV-maytansine conjugate specifically binds to low-density lipoprotein receptors on tumor cells, which are not present in normal cells. This results in an antitumor response that is more specific for tumor cells than traditional chemotherapy drugs such as trastuzumab, which can have severe side effects. NSC 153858 has been found to have minimal toxicity in animal studies and has shown promising antitumor activity in vitro against hl-60 cells and breast cancer cell lines.
Propiedades químicas
Consulta técnica sobre: 3D-FM29496 NSC 153858
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.